Lv2
200 积分 2024-04-15 加入
Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: A joint SITC and INMC effort
6个月前
已关闭
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
9个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
9个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
9个月前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
9个月前
已完结
Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
9个月前
已完结
Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung Cancer
10个月前
已关闭
Hypertrophic cardiomyopathy in childhood
10个月前
已完结
Left ventricular outflow tract obstruction: A narrative review for emergency clinicians
10个月前
已完结
Antibody–drug conjugates for cancer
10个月前
已完结
皖公网安备34019202002308
